Overview

|

Anjel Bonilla is an Attorney in the Firm’s Los Angeles office and a member of the Corporate practice group. Ms. Bonilla’s practice focuses on various capital markets transactions, including initial public offerings, note offerings and SPAC and de-SPAC transactions.

  • Represented BioAtla, Inc., a clinical-stage biotechnology company, in its $65 Million underwritten offering of its common stock.
  • Represented Ipsen, a global biopharmaceutical company, in its acquisition of Epizyme, Inc.
  • Represented Fisker Inc. in its up to $350 million at-the-market offering launched in May 2022.
  • Represented 890 5th Avenue Partners, Inc., a special purpose acquisition company, in its $1.5 billion merger with BuzzFeed.
  • Represented Keyarch Acquisition Corporation, a special purpose acquisition company sponsored by an affiliate of Keywise Capital, in its $100 million initial public offering and full exercise of over-allotment option.
  • Represented Genesis Growth Tech Acquisition Corp., a special purpose acquisition company sponsored by an affiliate of Genesis Advisors, in its upsized $220 million initial public offering and full exercise of over-allotment option.

Admissions

  • California

Education

  • Boston University School of Law, J.D.
    • Editor of the Review of Banking & Financial Law
  • University of California, San Diego, B.A., Economics, cum laude